SCHEMBL25845849

SCHEMBL25845849

COC(=O)C(F)C1COc2cc(OCc3cc(NC(=O)OC(C)(C)C)cc4c3OCO4)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 2/20 0.36
DRD2 P14416 2/20 0.34
HTR2A P28223 2/20 0.34
DRD3 P35462 2/20 0.34
RAB9A P51151 3/20 0.32
NPC1 O15118 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
FFAR1 O14842 3/20 0.32
PPARG P37231 2/20 0.32
PPARD Q03181 2/20 0.32
KMT2A Q03164 1/20 0.32
ACHE P22303 1/20 0.32
MAPT P10636 1/20 0.32
KDM4D Q6B0I6 2/20 0.32
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25846492 0.93 CD274 (0.38) CD274RAB9ANPC1FFAR1PPARG
SCHEMBL25845812 0.84 CD274 (0.40) CD274RAB9ANPC1FFAR1PPARG
SCHEMBL25845828 0.84 CD274 (0.40) CD274FFAR1PPARGPPARD
SCHEMBL25845682 0.83 FFAR1 (0.42) FFAR1PPARGPPARD
SCHEMBL25845680 0.83 FFAR1 (0.42) FFAR1PPARGPPARD
SCHEMBL25846371 0.82 FFAR1 (0.51) FFAR1PPARGPPARD
SCHEMBL25844258 0.82 FFAR1 (0.51) FFAR1PPARGPPARD
SCHEMBL25845716 0.80 CD274 (0.42) CD274DRD2HTR2ADRD3RAB9A
SCHEMBL25845717 0.77 FFAR1 (0.43) FFAR1PPARGPPARD
SCHEMBL25846397 0.77 PPARD (0.52) FFAR1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-10-26 US disclosed
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-10-26 US disclosed
EP-4212528-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUND AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF GPR55, GPR65, GPR4 CD274 3189/4885DRD2 1161/4885HTR2A 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.